Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B- derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 8229-8233

  Girard, Marc ^a   Yue, Ling ^b   Barré Sinoussi, Françoise ^a   Van Der Ryst, Elna ^a   Meignier, Bernard ^c   Muchmore, Elizabeth ^d   Fultz, Patricia N ^b  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c Pasteur Merieux Serums et Vaccins   (France)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT FAILURE; VACCINATION; VIRUS TYPING;

EID: 0029824283     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.8229-8233.1996     Document Type: Article

References (31)

1. Barre-Sinoussi, F., M.-C. Georges-Courbot, P. N. Fultz, H. N. T. Tuyet, E. Muchmore, S. Saragosti, G. Dubreuil, A. Georges, E. vander Ryst, and M. Girard. Characterization and titration of an HIV-1 subtype E chimpanzee challenge stock. Submitted for publication.
2. Berman, P. W., T. J. Gregory, L. Riddle, G. R. Nakamura, M. A. Champe, J. P. Porter, F. M. Wurm, R. D. Hershberg, E. K. Cobb, and J. W. Eichberg. 1990. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature (London) 345: 622-625.
3. Berman, P. W., K. K. Murthy, T. Wrin, J. C. Vennari, E. K. Cobb, D. J. Eastman, M. Champe, G. R. Nakamura, D. Davison, M. F. Powell, J. Bussiere, D. P. Francis, T. Matthews, T. J. Gregory, and J. F. Obijeske. 1996. Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. J. Infect. Dis. 173:52-59.
4. Bruck, C., C. Thiriart, L. Fabry, M. Francotte, P. Pala, O. Van Opstal, J. Culp, M. Rosenberg, M. DeWilde, P. Heidt, and J. Heeney. 1994. HIV-1 envelope-elicited neutralizing antibody titers correlate with protection and virus load in chimpanzees. Vaccine 12:1141-1148.
5. Chameau, P., A. M. Borman, C. Quillent, D. Guetard, S. Chamaret, J. Cohen, G. Remy, L. Montagnier, and F. Clavel. 1994. Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 205:247-253.
6. Esparza, J., and S. Osmanov. 1993. The development and evaluation of HIV vaccines. Curr. Opin. Infect. Dis. 6:218-229.
7. Fultz, P. N. Unpublished data.
8. Fultz, P. N., H. M. McClure, R. B. Swenson, C. R. McGrath, A. Brodie, J. P. Getchell, F. C. Jensen, D. C. Anderson, J. R. Broderson, and D. P. Francis. 1986. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J. Virol. 58:116-124.
9. Fultz, P. N., P. Nara, F. Barre-Sinoussi, A. Chaput, M. L. Greenberg, E. Muchmore, M.-P. Kieny, and M. Girard. 1992. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 256:1687-1690.
10. Gao, F., L. Yue, S. C. Hill, D. L. Robertson, A. H. Graves, M. S. Saag, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1994. HIV-1 sequence subtype D in the United States. AIDS Res. Hum. Retroviruses 10:625-627.
11. Girard, M. Unpublished data.
12. Girard, M., M.-P. Kieny, A. Pinter, F. Barre-Sinoussi, P. Nara, H. Kolbe, K. Kusumi, A. Chaput, T. Reinhart, E. Muchmore, J. Ranco, M. Kaczorek, E. Gomard, J.-C. Gluckman, and P. N. Fultz. 1991. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88:542-546.
13. Girard, M., J. Mahoney, L. Rimsky, F. Barre-Sinoussi, E. Muchmore, K. Weinhold, and P. Fultz. 1992. HIV-1 genital infection: a chimpanzee model, p. 75-79. In M. Girard and L. Valette (ed.), Retroviruses of human AIDS and related animal diseases. Fondation Merieux, Lyon, France.
14. Girard, M., B. Meignier, F. Barré-Sinoussi, M.-P. Kieny, T. Matthews, E. Muchmore, P. L. Nara, Q. Wei, L. Rimsky, K. Weinhold, and P. N. Fultz. 1995. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J. Virol. 69:6239-6248.
15. Gurtler, L. G., P. H. Hauser, J. Eberle, A. von Brunn, S. Knapp, L. Zekeng, J. M. Tsague, and L. Kaptue. 1994. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J. Virol. 68:1581-1585.
16. Janssens, W., L. Heyndrickx, K. Fransen, J. Motte, M. Peeters, J. N. Nkengasong, P. M. Ndumbe, E. Delaporte, J.-L. Perret, C. Atende, P. Piot, and G. van der Groen. 1994. Genetic and phylogenetic analysis of env subtypes G and H in Central Africa. AIDS Res. Hum. Retroviruses 10:877-879.
17. Kostrikis, L. G., E. Bagdades, Y. Can, L. Zhang, D. Dimitriou, and D. D. Ho. 1995. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J. Virol. 69:6122-6130.
18. Kostrikis, L. G., Y. Cao, H. Ngai, J. P. Moore, and D. D. Ho. 1996. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and 1: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J. Virol. 70:445-458.
19. Leitner, T., D. Escanilla, S. Marquina, J. Wahlberg, C. Brostrom, H. B. Hansson, M. Uhlen, and J. Albert. 1995. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. Virology 209:136-146.
20. Louwagie, J., W. Janssens, J. Mascola, L. Heyndrickx, P. Hegerich, G. van der Groen, F. E. McCutchan, and D. S. Burke. 1995. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69:263-271.
21. Mascola, J. R., M. Loudel, S. Surman, J. Bradac, K. R. Porter, J. Carr, C. Mason, J. G. McNeil, D. L. Birx, F. E. McCutchan, and D. S. Burke. 1996. An approach to human immunodeficiency virus type-1 neutralizing antibody serotyping, p. 65-72. In M. Girard and B. Dodet (ed.), Retroviruses of human AIDS and related animal diseases. Elsevier, Amsterdam.
22. Moore, J. P., Y. Cao, J. Leu, L. Qin, B. Korber, and D. D. Ho. 1996. Interand intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J, Virol. 70:427-444.
23. Moore, J. P., F. E. McCutchan, S.-W. Poon, J. Mascola, J. Liu, Y. Cao, and D. D. Ho. 1994. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J. Virol. 68:8350-8364.
24. Murphy, E., B. Korber, M.-C. Georges-Courbot, B. You, A. Pinter, D. Cook, M.-P. Kieny, A. Georges, C. Mathiot, F. Barre-Sinoussi, and M. Girard. 1993. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the Central African Republic. AIDS Res. Hum. Retroviruses 9:997-1006.
25. Myers, G., B. Korber, S. Wain-Hobson, K.-T. Jeang, L. E. Henderson, and G. N. Pavlakis. 1994. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.Mex.
26. Ou, C.-Y., Y. Takebe, B. G. Weniger, C.-C. Luo, M. L, Kalish, W. Auwanit, S. Yamazaki, H. D. Gayle, N. L. Young, and G. Schochetman. 1993. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 341:1171-1174.
27. Piot, P., and M. Laga. 1994. Epidemiology of AIDS in the developing world, p. 109-132. In S. Broder, T. C. Merigan, and D. P. Bolognesi (ed.), Textbook of AIDS medicine. Williams & Wilkins, Baltimore.
28. Simmonds, P., P. Balfe, J. F. Peutherer, C. A. Ludlam, J. O. Bishop, and A. J. L. Brown. 1990. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64:864-872.
29. Trkola, A., A. B. Pomales, H. Yuan, B. Korber, P. J. Maddon, G. P. Allaway, H. Katinger, C. F. Barbas III, D. R. Burton, D. D. Ho, and J. P. Moore. 1995. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 69:6609-6617.
30. Vanden Haesevelde, M., J.-L. Decourt, R. J. De Leys, B. Vanderborght, G. van der Groen, H. van Heuverswijn, and E. Saman. 1994. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J. Virol. 68:1586-1596.
31. WHO Network for HIV Isolation and Characterization. 1994. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res. Hum. Retroviruses 10:1327-1343.